首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective
【24h】

Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective

机译:金属螯合碎片中的药用化学术中的螯合碎片积极场所:一种观点

获取原文
获取原文并翻译 | 示例
           

摘要

Numerous metal-containing enzymes (metalloenzymes) have been considered as drug targets related to diseases such as cancers, diabetes, anemia, AIDS, malaria, bacterial infection, fibrosis, and neurodegenerative diseases. Inhibitors of the metalloenzymes have been developed independently, most of which are mimics of substrates of the corresponding enzymes. However, little attention has been paid to the interactions between inhibitors and active site metal ions. This review is focused on different metal binding fragments and their chelating properties in the metal-containing active binding pockets of metalloenzymes. We have enumerated over one hundred of inhibitors targeting various metalloenzymes and identified over ten kinds of fragments with different binding patterns. Furthermore, we have investigated the inhibitors that are undergoing clinical evaluation in order to help looking for more potential scaffolds bearing metal binding fragments. This review will provide deep insights for the rational design of novel inhibitors targeting the metal-containing binding sites of specific proteins. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:许多含金属酶(金属酶)被认为是与癌症,糖尿病,贫血,艾滋病,疟疾,细菌感染,纤维化和神经变性疾病相关的药物靶标。金属酶的抑制剂已独立地开发,其中大部分是相应酶的底物的模拟。但是,对抑制剂和活性位点金属离子之间的相互作用已经很少注意。本综述专注于不同的金属结合片段及其在含金属的含金属粘合袋中的螯合性质。我们已经列举了超过靶向各种金属酶的抑制剂,并鉴定出具有不同结合模式的十种片段。此外,我们研究了正在进行临床评估的抑制剂,以帮助寻找更多潜在的支架,轴承金属结合片段。本综述将为靶向含金属粘合位点的特定蛋白质的新型抑制剂的合理设计提供深切的见解。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号